• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / ETFs

Cannabis ETFs Could Soon Turn a New Leaf

With likely passage of new legislation, the pot industry might have a remedy for the nausea it gave investors.
By MARK ABSSY
Dec 08, 2022 | 01:11 PM EST
Stocks quotes in this article: MSOS, GTBIF, CURLF, TCNNF, PW, GRAMF, GDNSF, THCX, MJUS, SMG, PM, MO

It's often been said that one of the benefits of smoking cannabis as opposed to drinking alcohol is that you'll never wake up with a hangover. As you can tell from the below graph, investing in cannabis has been a whole other story since the sector's euphoric high in early 2021.

We have seen some brief rallies late in 2021 and a couple of points in 2022, mostly on speculation on the advancement of the SAFE Banking Act, but essentially, the sector has gone from a triple in first quarter 2021 to getting cut in half (or worse for some) as of Wednesday.

Source: Factset, All You Can ETF

What caught my eye about this sector is that so far, through the current quarter, cannabis funds have been, for the most part, seeing some steady growth as you can see in the table below. I figured I'd take a look at some of these funds and see what's driving returns and try and figure out if the sector has finally put in a base or if this is another head fake.

Source: Factset, All You Can ETF

Fourth-Quarter Drivers of Return

Let's look at the AdvisorShares Pure US Cannabis fund (MSOS) . Year to date, MSOS has fared fairly well considering some of the other funds' returns but what caught my eye was its much stronger quarter-to-date returns to Dec. 7.

MSOS was the first cannabis fund to provide exposure to companies that are directly involved with cannabis cultivation, preparation, and sales through the use of swaps. Because of this, and its focus on the North American cannabis market, it is widely regarded as the standard bearer for exchange-traded fund-based cannabis exposure. The pure-play nature of the fund, coupled with its concentrated position in Green Thumb Industries (GTBIF)  (22.72%), Curaleaf Holdings (CURLF)  (18.12%), and Trulieve Cannabis (TCNNF)  (17.21%) helped the fund achieve its 25.48% quarter-to-date return to Dec. 7. These three names were the top 3 contributors to return and by my calculations accounted for roughly 66% of fund return over the period. It wasn't a pretty time for all of MSOS holdings as Power REIT (PW) , TPCO Holding Corp (GRAMF) , and Goodness Growth Holdings (GDNSF)  all fell just over 60% quarter to date. Power REIT just recently cleared a hurdle with Marengo County, MI officials that open up the way for the shift of a former pepper growing facility to a cannabis growing facility which assumedly will benefit the company going forward. GRAMF was punished by investors as it exited the bulk wholesale extraction business at the end of the third quarter and GDNSF fell over suitor Verano Holdings scuttling the deal to acquire GDNSF.

In looking at some of the other funds, while a few have some of the same type of exposures as MSOS, they are not as focused or as concentrated. For example, the Cannabis ETF (THCX) shares only three names in common with MSOS. MJ has a 25% allocation to its MSOS clone ETFMG US Alternative Harvest ETF  (MJUS) , but then also has positions in names like Scott Miracle Grow (SMG) , Philip Morris (PM) , and Altria Group (MO) , which in my opinion simply don't provide enough exposure to the cannabis space.

My Take

From looking at the graph, what I like about it is that these latest gains haven't come in the form of a sharp spike due to a reaction to some headline. There does seem to be a base of sorts that has been created. Now, it is true that MSOS as well as some of its portfolio holdings spiked for a day on speculation about the SAFE Banking Act being included in the National Defense Authorization Act, but even though it gave those gain back almost immediately, the quarter to date returns in the table above are what they are, meaning even though hopes were dashed once again the bottom did not fall out of the market on these names. Further, the sponsor of the bill, Rep. Ed Perlmutter (D-CO) has contingent plans to attach the bill to upcoming appropriations legislation, and even if that fails, the hope is that he and the Democrats can muster the 60 votes needed to pass the bill as a standalone piece of legislation.

Cannabis retail markets have proven to be resilient and a powerful source of tax revenue for those states that have created a suitable framework to support the industry. My take is that ultimately, love of greenbacks will win out over fear of the green sometimes referred to as "the devil's lettuce." Further, the SAFE Banking Act will make its way into law during this administration and significantly boost the entire sector in both the short- and long-term.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Abssy owned shares of MSOS and options on MSOS.

TAGS: ETFs | Investing | Stocks | Cannabis

More from ETFs

When It Comes to Politics and ETFs, If You Can't Beat 'Em, Join 'Em

Mark Abssy
Feb 7, 2023 2:17 PM EST

Surprise! Lawmakers, no matter the party, are not exempt from insider-trading laws, just like the rest of us. But we can all invest in these two new exchange-traded funds.

I Found a Good-Looking Arrowhead in This Biotech ETF

Bruce Kamich
Feb 3, 2023 12:50 PM EST

Let's review the charts of XBI, the SPDR S&P Biotech ETF.

You Can Defy the Fed, but Don't Expect These Funds to Defy Gravity

Mark Abssy
Feb 2, 2023 1:32 PM EST

The Roundhill MEME, SoFi Web3, Proshares Metaverse and other 'innovation'-type exchange-traded fund names are up in January, but do you really expect them to stay up? Here's how I'd play them, if I were to play them.

Want Exposure to the Collateralized Loan Obligation Market? Check Out This ETF

Mark Abssy
Jan 31, 2023 1:00 PM EST

Asset manager Panagram Structured Asset Management launched the fund just a few days ago.

Here's a Trading Plan for Bulls Who Want to Know What to Do With the QQQ

Bob Byrne
Jan 31, 2023 8:30 AM EST

A hint: It does not involve chasing strength in the index fund, especially with the Fed rate hike announcement and earnings report galore on the horizon.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:22 AM EST REAL MONEY

    LIVE EVENT: Bruce Kamich and Todd Campbell Share Their Stock Market Insights

    This Monday, Feb. 6 at 12 p.m., our very own exper...
  • 02:58 PM EST REAL MONEY

    Sarge Guilfoyle Breaks Down the Jobs Report, Fed Policy and Stocks!

    Watch it here!
  • 11:35 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Trading an Irrational Market
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login